Skip to main content
Clinical Trials/NCT02690675
NCT02690675CompletedNot Applicable

Iron Supplement Effect Over Immune System and Neurobehavioral Child Development.

University Rovira i Virgili0 sites133 target enrollmentStarted: May 1, 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
133
Primary Endpoint
Mental and psychomotor development with BSID (Bayley Scale of Infant Development) at 12 months.

Study Overview

Brief Summary

Objective: To evaluate the effect of Iron supplement with two different amounts (one in the higher limit and another in the lower limit of the suggested amount) according to the presence of mutations in the HFE gene in the physical, immune and neurobehavioral development in the 6 to 12 moth toddlers.

Methodology: Subjects: 340 toddlers coming from Paediatric Serves of Sant Joan Hospital. Methods: At 6 and 12 months it done clinical history, food registry, biochemist determinations: haemoglobin, iron, transferrin, ferritin, reactive C protein and immune response (IL4, IL10, IL6 IFN, IgA, IgM, IgG, IgE). Mutations in the HFE gene: C282Y, H63D, S65D and hepcidin gene. Mental, psychomotor and behavioual development (Bayley Scales of Infant Development 2on Edition: 1993). We evaluate the level of language and communication (MacArthur), regulation and sensory process (Infant Toddler Symptom Checklist), familiar and environment surroundings (Scale Health General Parental Stress Index).

Detailed Description

Design: Randomised Clinical Trial with two groups of intervention. Group A received high-iron fortified milk (1.2mg/100mL) and Group B received low-iron fortified milk (0.4mg/100mL).

Inclusion criteria: caucasian new-borns, term infants.

Exclusion criteria:

  • Families that refuse enter at the follow-up.
  • Low-birth weight or preterm infants.
  • Anaemic infants.
  • Infants with congenital defects, immunodeficiency or hypothyroidism.
  • Infants with diseases that requires intensive care.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
— to 6 Months (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Caucasian infants
  • Healthy term infants

Exclusion Criteria

  • Families that do not understand Spanish or Catalan
  • Anaemic infants at birth
  • Infants with important diseases

Outcomes

Primary Outcomes

Mental and psychomotor development with BSID (Bayley Scale of Infant Development) at 12 months.

Time Frame: 12 months

Secondary Outcomes

  • Risk of infections at 12 months measured qualitatively from record of presence or not of various infections as bronchitis, rhinitis, otitis etc.(12 months)
  • Height at 12 months measured in centimeters(12 months)
  • Weight at 12 months measured in grams(12 months)
  • Head circumference at 12 months measured in centimeters(12 months)

Investigators

Sponsor
University Rovira i Virgili
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Victoria Arija Val

University Professor

University Rovira i Virgili

Similar Trials